Diminished Natriuretic Response to Dopamine D1 Receptor Agonist, SKF-38393 in Obese Zucker Rats

Clinical and Experimental Hypertension

Volumn 25, Issue 8, 2003, Pages 509-515

  Marwaha, Aditi ^a   Lokhandwala, Mustafa F ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; SODIUM; THIOBUTABARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIURETIC ACTIVITY; DRUG EFFECT; DRUG RESPONSE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART RATE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; RAT; RAT STRAIN; SODIUM URINE LEVEL;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BLOOD GLUCOSE; DOPAMINE AGONISTS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; KIDNEY; MALE; MODELS, ANIMAL; NATRIURESIS; NATRIURETIC AGENTS; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, DOPAMINE D1; SODIUM;

EID: 0344464834     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120025334     Document Type: Article

References (13)

1. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med 2003; 228:134-142.
2. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62:621-647.
3. Felder RA, Eisner GM, Jose P. D1 dopamine receptor signaling defect in spontaneous hypertension. Acta Physiol Scand 2002; 168:245-250.
4. Hall JE. The kidney, hypertension and obesity. Hypertension 2003; 41:625-633.
5. Hussain T, Becker M, Beheray S, Lokhandwala MF. Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats. Clin Exp Hypertens 2001; 23:591-601.
6. Hussain T, Beheray SA, Lokhandwala MF. Defective dopamine receptor function in proximal tubules of obese zucker rats. Hypertension 1999; 34:1091-1096.
7. Segers O, Anckaert E, Gerlo E, Dupont AG, Somers G. Dopamine-sodium relationship in type 2 diabetic patients. Diabetes Res Clin Pract 1996; 34:89-98.
8. Murabayashi S, Baba T, Tomiyama T, Takebe K. Urinary dopamine, noradrenaline and adrenaline in type 2 diabetic patients with and without nephropathy. Horm Metab Res 1989; 21:27-32.
9. Banday AA, Asghar M, Hussain T, Lokhandwala MF. Dopamine-mediated inhibition of renal Na,K-Atpase is reduced by insulin. Hypertension 2003; 41:1353-1358.
10. Kuroda S, Uzu T, Fujii T, Nishimura M, Nakamura S, Inenaga T, Kimura G. Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension. J Hum Hypertens 1999; 13:257-262.
11. Wong F, Blendis L, Logan A. Effects of insulin on renal function, sympathetic nervous activity and forearm blood flow in normal human subjects. Clin Invest Med 1997; 20:344-353.
12. Roysommuti S, Khongnakha T, Jirakulsomchok D, Wyss JM. Excess dietary glucose alters renal function before increasing arterial pressure and inducing insulin resistance. Am J Hypertens 2002; 15:773-779.
13. Umrani DN, Banday AA, Hussain T, Lokhandwala MF. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats. Hypertension 2002; 40:880-885.